P2Y receptors: In the middle of the road

Trends in Pharmacological Sciences

Volumn 21, Issue 1, 2000, Pages 1-3

  Boeynaems, Jean Marie ^a   Communi, Didier ^a   Savi, Pierre ^b   Herbert, Jean Marc ^b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ANTICOAGULANT AGENT; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE;

ANTICOAGULATION; CELL DIFFERENTIATION; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME INHIBITION; GRANULOPOIESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION;

ADENYLATE CYCLASE; HUMANS; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 0033967011     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01415-7     Document Type: Conference Paper

References (8)

1. Communi D., Boeynaems J-M. Receptors responsive to extracellular pyrimidine nucleotide. Trends Pharmacol. Sci. 18:1997;83-86.
2. King B.F.et al. Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol. Sci. 19:1998;506-514.
3. Jiang L.et al. Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells. Biochem. Biophys. Res. Commun. 232:1997;626-630.
4. Kunapuli S. Multiple P2 receptor subtypes on platelets: a new interpretation of their function. Trends Pharmacol. Sci. 19:1998;391-394.
5. 1receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett. 403:1997;26-30.
6. Cattaneo M.et al. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet response to adenosine diphosphate. Blood. 80:1992;2787-2796.
7. Nurden P.et al. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. J. Clin. Invest. 95:1995;1612-1622.
8. 3 receptor. Mol. Pharmacol. 55:1999;1101-1107.